Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Pressure BioSciences Inc. PBIO

MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Reports Q3 2019 Financial Results, Provides Business Update

Posted on December 19, 2019 by MissionIR

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, services, and platform solutions to the worldwide life sciences industry, today announced financial results for the third quarter ended September 30, 2019, provided … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) to Host Teleconference to Discuss Q3 2019 Financial Results, Provide Business Update

Posted on December 18, 2019 by MissionIR

Pressure BioSciences (OTCQB: PBIO) (“PBI”) today announced that it will host a teleconference to discuss its third quarter 2019 financial results and to provide a business update. According to the update, Pressure BioSciences will include in the discussion progress made … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc.’s (PBIO) PCT Platform Highlighted at IGCS Conference in Brazil

Posted on October 23, 2019 by MissionIR

Pressure BioSciences’ (OTCQB: PBIO) patented pressure cycling technology (“PCT”) platform was recently described as an integral part of women’s cancer research efforts during a presentation at the International Gynecologic Cancer Society conference in Brazil. An article discussing the company reads, … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc.’s (PBIO) Proprietary PCT Platform Demonstrates Ability to Discover Cancer Biomarkers in Independent Research

Posted on October 14, 2019 by MissionIR

Pressure BioSciences’ (OTCQB: PBIO) pressure cycling technology (“PCT”) platform was recently the subject of independent research carried out by Chinese and Australian scientists in which the platform demonstrated its proficiency in processing of preserved (“FFPE”) and fresh frozen biopsy tissue … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc.’s (PBIO) BaroShear K45 System Creates Water-Soluble CBD Oil

Posted on October 10, 2019 by MissionIR

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, has developed a revolutionary CBD processing system, the BaroShear K45, which effectively solves the water … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

Pressure BioSciences Inc. (PBIO) Gains Praise Amid Disclosure of Innovative Research Tool to Aid Gynecological Cancer Diagnosis, Therapy

Posted on October 4, 2019 by MissionIR

Pressure BioSciences was described as an integral part of women’s cancer research efforts during a presentation last month at the International Gynecologic Cancer Society conference in Brazil The company’s patented pressure cycling technology provided a key link in a trio … Continue reading →

Posted in Pressure BioSciences Inc. PBIO, Small Cap News | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Initiation of Zacks Small Cap Research Coverage

Posted on October 4, 2019 by MissionIR

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced that Zacks Small Cap Research (“Zacks SCR”) has initiated coverage on the … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc.’s (PBIO) PCT Platform Fills Integral Role for Tumor Analyses in Novel Workflow Presented at IGCS

Posted on October 1, 2019 by MissionIR

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced that its patented pressure cycling technology (“PCT”) platform was featured as an … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc.’s (PBIO) Patented PCT Platform Highlighted in 10 Separate Presentations at International Human Proteome Organization World Congress

Posted on September 26, 2019 by MissionIR

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced that its patented pressure cycling technology (“PCT”) platform was prominently featured at … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

Pressure BioSciences Inc.’s (PBIO) Proprietary Technology Platform Identified as Key Cancer Biomarker Research Element

Posted on September 25, 2019 by MissionIR

Independent research carried out by Chinese and Australian scientists shows that the Pressure BioSciences Pressure Cycling Technology (PCT) platform is excellent for the processing of preserved (formalin-fixed paraffin-embedded, or FFPE) and fresh frozen biopsy tissues, which are considered invaluable for … Continue reading →

Posted in Pressure BioSciences Inc. PBIO | Leave a comment